{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:58:40Z","timestamp":1793066320903,"version":"4.5.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-OFLCG000207"],"award-info":[{"award-number":["MOH-OFLCG000207"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001580"],"award-info":[{"award-number":["MOH-001580"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68325-3","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T17:37:07Z","timestamp":1768844227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Glycerol 3-phosphate acyltransferase exacerbates \u03b1-synuclein-induced toxicity by increasing lipid peroxidation"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2429-5539","authenticated-orcid":false,"given":"Mengda","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace G. Y.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3739-1784","authenticated-orcid":false,"given":"Willcyn","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5440-2588","authenticated-orcid":false,"given":"Kah-Leong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"68325_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease.  Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"68325_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5607\/en.2013.22.2.77","volume":"22","author":"HJ Kim","year":"2013","unstructured":"Kim, H. J. Alpha-synuclein expression in patients with Parkinson\u2019s disease: a clinician\u2019s perspective. Exp. Neurobiol. 22, 77\u201383 (2013).","journal-title":"Exp. Neurobiol."},{"key":"68325_CR3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.parkreldis.2008.08.002","volume":"15","author":"A Puschmann","year":"2009","unstructured":"Puschmann, A. et al. Alpha-synuclein multiplications with Parkinsonism, dementia or progressive myoclonus? Parkinsonism Relat. Disord. 15, 390\u2013392 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"68325_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger, R. et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat. Genet. 18, 106\u2013108 (1998).","journal-title":"Nat. Genet."},{"key":"68325_CR5","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276, 2045\u20132047 (1997).","journal-title":"Science"},{"key":"68325_CR6","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"68325_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3389\/fnmol.2018.00391","volume":"11","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. A comprehensive analysis of the association between SNCA polymorphisms and the risk of Parkinson\u2019s disease. Front. Mol. Neurosci. 11, 391 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"68325_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1073\/pnas.1119675109","volume":"109","author":"O Zuk","year":"2012","unstructured":"Zuk, O., Hechter, E., Sunyaev, S. R. & Lander, E. S. The mystery of missing heritability: genetic interactions create phantom heritability. Proc. Natl. Acad. Sci. USA 109, 1193\u20131198 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68325_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldv022","volume":"114","author":"S Mullin","year":"2015","unstructured":"Mullin, S. & Schapira, A. The genetics of Parkinson\u2019s disease. Br. Med. Bull. 114, 39\u201352 (2015).","journal-title":"Br. Med. Bull."},{"key":"68325_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/oons\/kvad001","volume":"2","author":"RMQ Lee","year":"2023","unstructured":"Lee, R. M. Q. & Koh, T.-W. Genetic modifiers of synucleinopathies\u2014lessons from experimental models. Oxf. Open Neurosci. 2, 1\u201330 (2023).","journal-title":"Oxf. Open Neurosci."},{"key":"68325_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00401-021-02329-9","volume":"142","author":"TE Moors","year":"2021","unstructured":"Moors, T. E. et al. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson\u2019s disease brain as revealed by multicolor STED microscopy. Acta Neuropathol. 142, 423\u2013448 (2021).","journal-title":"Acta Neuropathol."},{"key":"68325_CR12","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian, S. H. et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099\u20131109 (2019).","journal-title":"Nat. Neurosci."},{"key":"68325_CR13","doi-asserted-by":"publisher","first-page":"7630","DOI":"10.3390\/ijms22147630","volume":"22","author":"M Fais","year":"2021","unstructured":"Fais, M. et al. Parkinson\u2019s disease-related genes and lipid alteration. Int. J. Mol. Sci. 22, 7630 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"68325_CR14","first-page":"1","volume":"0","author":"J Galper","year":"2022","unstructured":"Galper, J. et al. Lipid pathway dysfunction is prevalent in patients with Parkinson\u2019s disease. Brain 0, 1\u201316 (2022).","journal-title":"Brain"},{"key":"68325_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41589-020-00734-x","volume":"17","author":"W-Y Sun","year":"2021","unstructured":"Sun, W.-Y. et al. Phospholipase iPLA2\u03b2 averts ferroptosis by eliminating a redox lipid death signal. Nat. Chem. Biol. 17, 465\u2013476 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"68325_CR16","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.3390\/ijms23116235","volume":"23","author":"V Chiurchi\u00f9","year":"2022","unstructured":"Chiurchi\u00f9, V. et al. Lipidomics of bioactive lipids in Alzheimer\u2019s and Parkinson\u2019s diseases: where are we? Int. J. Mol. Sci. 23, 6235 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"68325_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41531-022-00313-y","volume":"8","author":"H Avisar","year":"2022","unstructured":"Avisar, H. et al. Lipid level alteration in human and cellular models of alpha synuclein mutations. NPJ Parkinson\u2019s. Dis. 8, 52 (2022).","journal-title":"NPJ Parkinson\u2019s. Dis."},{"key":"68325_CR18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fnins.2019.00328","volume":"13","author":"I Alecu","year":"2019","unstructured":"Alecu, I. & Bennett, S. A. L. Dysregulated lipid metabolism and its role in \u03b1-synucleinopathy in Parkinson\u2019s disease. Front. Neurosci. 13, 328 (2019).","journal-title":"Front. Neurosci."},{"key":"68325_CR19","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.3390\/ijms21093301","volume":"21","author":"A Mori","year":"2020","unstructured":"Mori, A., Imai, Y. & Hattori, N. Lipids: key players that modulate \u03b1-synuclein toxicity and neurodegeneration in Parkinson\u2019s disease. Int. J. Mol. Sci. 21, 3301 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"68325_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1006\/jmbi.2001.5269","volume":"315","author":"E Jo","year":"2002","unstructured":"Jo, E., Fuller, N., Rand, R. P., St George-Hyslop, P. & Fraser, P. E. Defective membrane interactions of familial Parkinson\u2019s disease mutant A30P alpha-synuclein. J. Mol. Biol. 315, 799\u2013807 (2002).","journal-title":"J. Mol. Biol."},{"key":"68325_CR21","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1523\/JNEUROSCI.1881-21.2022","volume":"42","author":"A Tripathi","year":"2022","unstructured":"Tripathi, A. et al. Pathogenic mechanisms of cytosolic and membrane-enriched \u03b1-synuclein converge on fatty acid homeostasis.  J. Neurosci. 42, 2116\u20132130 (2022).","journal-title":"J. Neurosci."},{"key":"68325_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1471-4159.2006.04348.x","volume":"101","author":"G Barcel\u00f3-Coblijn","year":"2007","unstructured":"Barcel\u00f3-Coblijn, G., Golovko, M. Y., Weinhofer, I., Berger, J. & Murphy, E. J. Brain neutral lipids mass is increased in alpha-synuclein gene-ablated mice. J. Neurochem 101, 132\u2013141 (2007).","journal-title":"J. Neurochem"},{"key":"68325_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1471-4159.2006.04357.x","volume":"101","author":"MY Golovko","year":"2007","unstructured":"Golovko, M. Y., Rosenberger, T. A., Feddersen, S., Faergeman, N. J. & Murphy, E. J. Alpha-synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids. J. Neurochem 101, 201\u2013211 (2007).","journal-title":"J. Neurochem"},{"key":"68325_CR24","doi-asserted-by":"publisher","first-page":"8251","DOI":"10.1021\/bi0502137","volume":"44","author":"MY Golovko","year":"2005","unstructured":"Golovko, M. Y. et al. \u03b1-Synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of \u03b1-synuclein palmitate binding. Biochemistry 44, 8251\u20138259 (2005).","journal-title":"Biochemistry"},{"key":"68325_CR25","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.1090439","volume":"302","author":"TF Outeiro","year":"2003","unstructured":"Outeiro, T. F. & Lindquist, S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302, 1772\u20131775 (2003).","journal-title":"Science"},{"key":"68325_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111231","volume":"40","author":"L Mahoney-Sanchez","year":"2022","unstructured":"Mahoney-Sanchez, L. et al. Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether-phospholipid membrane composition. Cell Rep. 40, 111231 (2022).","journal-title":"Cell Rep."},{"key":"68325_CR27","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1038\/s41418-020-0542-z","volume":"10","author":"PR Angelova","year":"2020","unstructured":"Angelova, P. R. et al. Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation. Cell Death Differ. 10, 2781\u20132796 (2020).","journal-title":"Cell Death Differ."},{"key":"68325_CR28","doi-asserted-by":"publisher","first-page":"20760","DOI":"10.1073\/pnas.1903216116","volume":"116","author":"T Imberdis","year":"2019","unstructured":"Imberdis, T. et al. Cell models of lipid-rich \u03b1-synuclein aggregation validate known modifiers of \u03b1-synuclein biology and identify stearoyl-CoA desaturase. Proc. Natl. Acad. Sci. USA 116, 20760\u201320769 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68325_CR29","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s13311-022-01199-7","volume":"19","author":"S Nuber","year":"2022","unstructured":"Nuber, S. et al. A brain-penetrant stearoyl-CoA desaturase inhibitor reverses \u03b1-synuclein toxicity. Neurotherapeutics 19, 1018\u20131036 (2022).","journal-title":"Neurotherapeutics"},{"key":"68325_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ana.25920","volume":"89","author":"S Nuber","year":"2021","unstructured":"Nuber, S. et al. A stearoyl-Coenzyme A desaturase inhibitor prevents multiple Parkinson disease phenotypes in \u03b1-synuclein mice. Ann. Neurol. 89, 74\u201390 (2021).","journal-title":"Ann. Neurol."},{"key":"68325_CR31","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.3390\/ijms21155193","volume":"21","author":"E Terry-Kantor","year":"2020","unstructured":"Terry-Kantor, E. et al. Rapid alpha-synuclein toxicity in a neural cell model and its rescue by a stearoyl-CoA desaturase inhibitor. Int. J. Mol. Sci. 21, 5193 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"68325_CR32","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1016\/j.celrep.2018.11.028","volume":"25","author":"BM Vincent","year":"2018","unstructured":"Vincent, B. M. et al. Inhibiting stearoyl-CoA desaturase ameliorates \u03b1-synuclein cytotoxicity. Cell Rep. 25, 2742\u20132754 (2018).","journal-title":"Cell Rep."},{"key":"68325_CR33","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1021\/bi0600289","volume":"45","author":"MY Golovko","year":"2006","unstructured":"Golovko, M. Y. et al. Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism. Biochemistry 45, 6956\u20136966 (2006).","journal-title":"Biochemistry"},{"key":"68325_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09277-9","volume":"10","author":"Y Zou","year":"2019","unstructured":"Zou, Y. et al. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat. Commun. 10, 1617 (2019).","journal-title":"Nat. Commun."},{"key":"68325_CR35","doi-asserted-by":"publisher","first-page":"136491","DOI":"10.1016\/j.neulet.2022.136491","volume":"772","author":"JW Nicholatos","year":"2022","unstructured":"Nicholatos, J. W., Tran, D., Liu, Y., Hirst, W. D. & Weihofen, A. Lysophosphatidylcholine acyltransferase 1 promotes pathology and toxicity in two distinct cell-based alpha-synuclein models. Neurosci. Lett. 772, 136491 (2022).","journal-title":"Neurosci. Lett."},{"key":"68325_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41531-022-00335-6","volume":"8","author":"S Fanning","year":"2022","unstructured":"Fanning, S. et al. Lipase regulation of cellular fatty acid homeostasis as a Parkinson\u2019s disease therapeutic strategy. NPJ Parkinson\u2019s. Dis. 8, 74 (2022).","journal-title":"NPJ Parkinson\u2019s. Dis."},{"key":"68325_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1147-9","volume":"18","author":"IE Jansen","year":"2017","unstructured":"Jansen, I. E. et al. Discovery and functional prioritization of Parkinson\u2019s disease candidate genes from large-scale whole exome sequencing. Genome Biol. 18, 22 (2017).","journal-title":"Genome Biol."},{"key":"68325_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41586-021-03211-0","volume":"591","author":"J Yan","year":"2021","unstructured":"Yan, J. et al. Systematic analysis of binding of transcription factors to noncoding variants. Nature 591, 147\u2013151 (2021).","journal-title":"Nature"},{"key":"68325_CR39","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1002\/mds.28197","volume":"35","author":"FP Grenn","year":"2020","unstructured":"Grenn, F. P. et al. The Parkinson\u2019s disease genome-wide association study locus browser. Mov. Disord. 35, 2056\u20132067 (2020).","journal-title":"Mov. Disord."},{"key":"68325_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-357","volume":"12","author":"Y Hu","year":"2011","unstructured":"Hu, Y. et al. An integrative approach to ortholog prediction for disease-focused and other functional studies. BMC Bioinforma. 12, 357 (2011).","journal-title":"BMC Bioinforma."},{"key":"68325_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111852","volume":"41","author":"M Ren","year":"2022","unstructured":"Ren, M. et al. MED13 and glycolysis are conserved modifiers of \u03b1-synuclein-associated neurodegeneration. Cell Rep. 41, 111852 (2022).","journal-title":"Cell Rep."},{"key":"68325_CR42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuron.2017.11.036","volume":"97","author":"DG Ordonez","year":"2018","unstructured":"Ordonez, D. G., Lee, M. K. & Feany, M. B. Alpha-synuclein induces mitochondrial dysfunction through spectrin and the actin cytoskeleton. Neuron 97, 108\u2013124 (2018).","journal-title":"Neuron"},{"key":"68325_CR43","doi-asserted-by":"crossref","unstructured":"Sun, J. et al. Neural control of startle-induced locomotion by the mushroom bodies and associated neurons in Drosophila. Front. Syst. Neurosci. 12, 6 (2018).","DOI":"10.3389\/fnsys.2018.00006"},{"key":"68325_CR44","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.celrep.2013.10.032","volume":"5","author":"T Riemensperger","year":"2013","unstructured":"Riemensperger, T. et al. A single dopamine pathway underlies progressive locomotor deficits in a Drosophila model of Parkinson disease. Cell Rep. 5, 952\u2013960 (2013).","journal-title":"Cell Rep."},{"key":"68325_CR45","doi-asserted-by":"crossref","unstructured":"Arzt, M. et al. Labkit: labeling and segmentation toolkit for big image data. Front. Comput. Sci. 4, 777728 (2022).","DOI":"10.3389\/fcomp.2022.777728"},{"key":"68325_CR46","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.neuron.2018.05.022","volume":"98","author":"JS Valadas","year":"2018","unstructured":"Valadas, J. S. et al. ER lipid defects in neuropeptidergic neurons impair sleep patterns in Parkinson\u2019s disease. Neuron 98, 1155\u20131169 (2018).","journal-title":"Neuron"},{"key":"68325_CR47","doi-asserted-by":"crossref","unstructured":"Cuvelier, E. et al. Overexpression of wild-type human alpha-synuclein causes metabolism abnormalities in Thy1-asyn transgenic mice. Front. Mol. Neurosci. 11, 321 (2018).","DOI":"10.3389\/fnmol.2018.00321"},{"key":"68325_CR48","doi-asserted-by":"publisher","first-page":"e24701","DOI":"10.1371\/journal.pone.0024701","volume":"6","author":"MB Gajula Balija","year":"2011","unstructured":"Gajula Balija, M. B., Griesinger, C., Herzig, A., Zweckstetter, M. & Jackle, H. Pre-fibrillar alpha-synuclein mutants cause Parkinson\u2019s disease-like non-motor symptoms in Drosophila. PLoS ONE 6, e24701 (2011).","journal-title":"PLoS ONE"},{"key":"68325_CR49","doi-asserted-by":"crossref","unstructured":"Mason, S. Lactate shuttles in neuroenergetics\u2014homeostasis, allostasis and beyond. Front. Neurosci. 11, 43 (2017).","DOI":"10.3389\/fnins.2017.00043"},{"key":"68325_CR50","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1261\/rna.039669.113","volume":"19","author":"VV Vagin","year":"2013","unstructured":"Vagin, V. V. et al. Minotaur is critical for primary piRNA biogenesis. Rna 19, 1064\u20131077 (2013).","journal-title":"Rna"},{"key":"68325_CR51","doi-asserted-by":"publisher","first-page":"E1195","DOI":"10.1152\/ajpendo.90958.2008","volume":"296","author":"K Takeuchi","year":"2009","unstructured":"Takeuchi, K. & Reue, K. Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis. Am. J. Physiol. Endocrinol. Metab. 296, E1195\u2013E1209 (2009).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"68325_CR52","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/jnc.13024","volume":"133","author":"PR Angelova","year":"2015","unstructured":"Angelova, P. R. et al. Lipid peroxidation is essential for \u03b1-synuclein-induced cell death. J. Neurochem 133, 582\u2013589 (2015).","journal-title":"J. Neurochem"},{"key":"68325_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101890","volume":"196","author":"L Mahoney-S\u00e1nchez","year":"2021","unstructured":"Mahoney-S\u00e1nchez, L. et al. Ferroptosis and its potential role in the physiopathology of Parkinson\u2019s disease. Prog. Neurobiol. 196, 101890 (2021).","journal-title":"Prog. Neurobiol."},{"key":"68325_CR54","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nmeth.3447","volume":"12","author":"D Yu","year":"2015","unstructured":"Yu, D. et al. A naturally monomeric infrared fluorescent protein for protein labeling in vivo. Nat. Methods 12, 763\u2013765 (2015).","journal-title":"Nat. Methods"},{"key":"68325_CR55","doi-asserted-by":"publisher","first-page":"13901","DOI":"10.1073\/pnas.0806983105","volume":"105","author":"PL Bardet","year":"2008","unstructured":"Bardet, P. L. et al. A fluorescent reporter of caspase activity for live imaging. Proc. Natl. Acad. Sci. USA 105, 13901\u201313905 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68325_CR56","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/nn1774","volume":"9","author":"DW Williams","year":"2006","unstructured":"Williams, D. W., Kondo, S., Krzyzanowska, A., Hiromi, Y. & Truman, J. W. Local caspase activity directs engulfment of dendrites during pruning. Nat. Neurosci. 9, 1234\u20131236 (2006).","journal-title":"Nat. Neurosci."},{"key":"68325_CR57","first-page":"435","volume":"92","author":"E Jarc","year":"2019","unstructured":"Jarc, E. & Petan, T. Lipid droplets and the management of cellular stress. Yale J. Biol. Med. 92, 435\u2013452 (2019).","journal-title":"Yale J. Biol. Med."},{"key":"68325_CR58","doi-asserted-by":"crossref","unstructured":"Listenberger, L. L. & Brown, D. A. Fluorescent detection of lipid droplets and associated proteins. Curr. Protoc. Cell Biol. Chapter 24, Unit 24.22 (2007).","DOI":"10.1002\/0471143030.cb2402s35"},{"key":"68325_CR59","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2014.12.019","volume":"160","author":"L Liu","year":"2015","unstructured":"Liu, L. et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell 160, 177\u2013190 (2015).","journal-title":"Cell"},{"key":"68325_CR60","doi-asserted-by":"publisher","first-page":"e1009921","DOI":"10.1371\/journal.pgen.1009921","volume":"17","author":"V Girard","year":"2021","unstructured":"Girard, V. et al. Abnormal accumulation of lipid droplets in neurons induces the conversion of alpha-synuclein to proteolytic resistant forms in a Drosophila model of Parkinson\u2019s disease. PLoS Genet. 17, e1009921 (2021).","journal-title":"PLoS Genet."},{"key":"68325_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/science.abk2432","volume":"375","author":"H Li","year":"2022","unstructured":"Li, H. et al. Fly Cell Atlas: A single-nucleus transcriptomic atlas of the adult fruit fly. Science 375, eabk2432 (2022).","journal-title":"Science"},{"key":"68325_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg0934","volume":"380","author":"TC Lu","year":"2023","unstructured":"Lu, T. C. et al. Aging Fly Cell Atlas identifies exhaustive aging features at cellular resolution. Science 380, eadg0934 (2023).","journal-title":"Science"},{"key":"68325_CR63","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.neuron.2023.02.033","volume":"111","author":"R Praschberger","year":"2023","unstructured":"Praschberger, R. et al. Neuronal identity defines \u03b1-synuclein and tau toxicity. Neuron 111, 1577\u20131590.e1511 (2023).","journal-title":"Neuron"},{"key":"68325_CR64","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2015.09.020","volume":"163","author":"AP Bailey","year":"2015","unstructured":"Bailey, A. P. et al. Antioxidant role for lipid droplets in a stem cell niche of Drosophila. Cell 163, 340\u2013353 (2015).","journal-title":"Cell"},{"key":"68325_CR65","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.cmet.2017.08.024","volume":"26","author":"L Liu","year":"2017","unstructured":"Liu, L., MacKenzie, K. R., Putluri, N., Maleti\u0107-Savati\u0107, M. & Bellen, H. J. The glia-neuron lactate shuttle and elevated ROS promote lipid synthesis in neurons and lipid droplet accumulation in glia via APOE\/D. Cell Metab. 26, 719\u2013737.e716 (2017).","journal-title":"Cell Metab."},{"key":"68325_CR66","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/ana.410350212","volume":"35","author":"Y Mizuno","year":"1994","unstructured":"Mizuno, Y. et al. An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson\u2019s disease. Ann. Neurol. 35, 204\u2013210 (1994).","journal-title":"Ann. Neurol."},{"key":"68325_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42862-7","volume":"14","author":"S Schmidt","year":"2023","unstructured":"Schmidt, S. et al. A reversible state of hypometabolism in a human cellular model of sporadic Parkinson\u2019s disease. Nat. Commun. 14, 7674 (2023).","journal-title":"Nat. Commun."},{"key":"68325_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57142-9","volume":"16","author":"G Gao","year":"2025","unstructured":"Gao, G., Shi, Y., Deng, H. X. & Krainc, D. Dysregulation of mitochondrial \u03b1-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson\u2019s disease models. Nat. Commun. 16, 1982 (2025).","journal-title":"Nat. Commun."},{"key":"68325_CR69","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1242\/bio.20149399","volume":"3","author":"Y Toyoda","year":"2014","unstructured":"Toyoda, Y. et al. Products of the Parkinson\u2019s disease-related glyoxalase DJ-1, D-lactate and glycolate, support mitochondrial membrane potential and neuronal survival. Biol. Open 3, 777\u2013784 (2014).","journal-title":"Biol. Open"},{"key":"68325_CR70","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.ejmech.2018.09.001","volume":"157","author":"C Granchi","year":"2018","unstructured":"Granchi, C. ATP citrate lyase (ACLY) inhibitors: an anti-cancer strategy at the crossroads of glucose and lipid metabolism. Eur. J. Med. Chem. 157, 1276\u20131291 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"68325_CR71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41531-020-00143-w","volume":"6","author":"S Sarkar","year":"2020","unstructured":"Sarkar, S. et al. Comparative proteomic analysis highlights metabolic dysfunction in \u03b1-synucleinopathy. NPJ Parkinson\u2019s. Dis. 6, 40 (2020).","journal-title":"NPJ Parkinson\u2019s. Dis."},{"key":"68325_CR72","doi-asserted-by":"crossref","unstructured":"Fanning, S. et al. Lipidomic analysis of \u03b1-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment. Mol. Cell 73, 1001\u20131014.e1008 (2019).","DOI":"10.1016\/j.molcel.2018.11.028"},{"key":"68325_CR73","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1016\/j.csbj.2021.08.027","volume":"19","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y. et al. MULocDeep: a deep-learning framework for protein subcellular and suborganellar localization prediction with residue-level interpretation. Comput. Struct. Biotechnol. J. 19, 4825\u20134839 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"68325_CR74","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1152\/ajpregu.00147.2011","volume":"301","author":"FP Kuhajda","year":"2011","unstructured":"Kuhajda, F. P. et al. Pharmacological glycerol-3-phosphate acyltransferase inhibition decreases food intake and adiposity and increases insulin sensitivity in diet-induced obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, 116\u2013130 (2011).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"68325_CR75","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","volume":"25","author":"ML Choi","year":"2022","unstructured":"Choi, M. L. et al. Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity. Nat. Neurosci. 25, 1134\u20131148 (2022).","journal-title":"Nat. Neurosci."},{"key":"68325_CR76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2208792120","volume":"120","author":"ST Dada","year":"2023","unstructured":"Dada, S. T. et al. Spontaneous nucleation and fast aggregate-dependent proliferation of \u03b1-synuclein aggregates within liquid condensates at neutral pH. Proc. Natl. Acad. Sci. USA 120, e2208792120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68325_CR77","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/mds.29283","volume":"38","author":"AL Olsen","year":"2023","unstructured":"Olsen, A. L., Clemens, S. G. & Feany, M. B. Nicotine-mediated rescue of \u03b1-synuclein toxicity requires synaptic vesicle glycoprotein 2 in Drosophila. Mov. Disord. 38, 244\u2013255 (2023).","journal-title":"Mov. Disord."},{"key":"68325_CR78","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1074\/jbc.M108414200","volume":"277","author":"NB Cole","year":"2002","unstructured":"Cole, N. B. et al. Lipid droplet binding and oligomerization properties of the Parkinson\u2019s disease protein alpha-synuclein. J. Biol. Chem. 277, 6344\u20136352 (2002).","journal-title":"J. Biol. Chem."},{"key":"68325_CR79","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.cmet.2011.10.010","volume":"14","author":"SC Albrecht","year":"2011","unstructured":"Albrecht, S. C., Barata, A. G., Grosshans, J., Teleman, A. A. & Dick, T. P. In vivo mapping of hydrogen peroxide and oxidized glutathione reveals chemical and regional specificity of redox homeostasis. Cell Metab. 14, 819\u2013829 (2011).","journal-title":"Cell Metab."},{"key":"68325_CR80","doi-asserted-by":"publisher","first-page":"12005","DOI":"10.1074\/jbc.M113.530527","volume":"289","author":"RC Laker","year":"2014","unstructured":"Laker, R. C. et al. A novel mitotimer reporter gene for mitochondrial content, structure, stress, and damage in vivo. J. Biol. Chem. 289, 12005\u201312015 (2014).","journal-title":"J. Biol. Chem."},{"key":"68325_CR81","doi-asserted-by":"publisher","first-page":"34328","DOI":"10.1074\/jbc.M004345200","volume":"275","author":"E Jo","year":"2000","unstructured":"Jo, E., McLaurin, J., Yip, C. M., St George-Hyslop, P. & Fraser, P. E. \u0391-synuclein membrane interactions and lipid specificity. J. Biol. Chem. 275, 34328\u201334334 (2000).","journal-title":"J. Biol. Chem."},{"key":"68325_CR82","doi-asserted-by":"crossref","unstructured":"Kiechle, M., Grozdanov, V. & Danzer, K. M. The role of lipids in the initiation of \u03b1-synuclein misfolding. Front. Cell Dev. Biol. 8, 562241 (2020).","DOI":"10.3389\/fcell.2020.562241"},{"key":"68325_CR83","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.bpj.2010.07.056","volume":"99","author":"ER Middleton","year":"2010","unstructured":"Middleton, E. R. & Rhoades, E. Effects of curvature and composition on \u03b1-synuclein binding to lipid vesicles. Biophys. J. 99, 2279\u20132788 (2010).","journal-title":"Biophys. J."},{"key":"68325_CR84","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nchembio.1750","volume":"11","author":"C Galvagnion","year":"2015","unstructured":"Galvagnion, C. et al. Lipid vesicles trigger \u03b1-synuclein aggregation by stimulating primary nucleation. Nat. Chem. Biol. 11, 229\u2013234 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"68325_CR85","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.tcb.2013.07.011","volume":"24","author":"T Tatsuta","year":"2014","unstructured":"Tatsuta, T., Scharwey, M. & Langer, T. Mitochondrial lipid trafficking. Trends Cell Biol. 24, 44\u201352 (2014).","journal-title":"Trends Cell Biol."},{"key":"68325_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-3-12","volume":"3","author":"X-L Gu","year":"2010","unstructured":"Gu, X.-L. et al. Astrocytic expression of Parkinson\u2019s disease-related A53T -synuclein causes neurodegeneration in mice. Mol. Brain 3, 12 (2010).","journal-title":"Mol. Brain"},{"key":"68325_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-4-9","volume":"4","author":"MR Cookson","year":"2009","unstructured":"Cookson, M. R. \u03b1-Synuclein and neuronal cell death. Mol. Neurodegener. 4, 9 (2009).","journal-title":"Mol. Neurodegener."},{"key":"68325_CR88","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","volume":"91","author":"M Yamada","year":"2004","unstructured":"Yamada, M., Iwatsubo, T., Mizuno, Y. & Mochizuki, H. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson\u2019s disease. J. Neurochem 91, 451\u2013461 (2004).","journal-title":"J. Neurochem"},{"key":"68325_CR89","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.chembiol.2020.03.014","volume":"27","author":"H Bay\u0131r","year":"2020","unstructured":"Bay\u0131r, H. et al. Achieving life through death: Redox biology of lipid peroxidation in ferroptosis. Cell Chem. Biol. 27, 387\u2013408 (2020).","journal-title":"Cell Chem. Biol."},{"key":"68325_CR90","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.3390\/cells11233829","volume":"11","author":"K-J Lin","year":"2022","unstructured":"Lin, K.-J. et al. Iron brain menace: the involvement of ferroptosis in Parkinson disease. Cells 11, 3829 (2022).","journal-title":"Cells"},{"key":"68325_CR91","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1194\/jlr.M008524","volume":"51","author":"LR Shen","year":"2010","unstructured":"Shen, L. R. et al. Drosophila lacks C20 and C22 PUFAs. J. Lipid Res 51, 2985\u20132992 (2010).","journal-title":"J. Lipid Res"},{"key":"68325_CR92","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/oxfordjournals.jbchem.a135322","volume":"98","author":"T Yoshioka","year":"1985","unstructured":"Yoshioka, T. et al. Evidence that arachidonic acid is deficient in phosphatidylinositol of Drosophila heads. J. Biochem 98, 657\u2013662 (1985).","journal-title":"J. Biochem"},{"key":"68325_CR93","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/0891-5849(94)00234-B","volume":"18","author":"L Guo","year":"1995","unstructured":"Guo, L., Ogamo, A., Ou, Z., Shinozuka, T. & Nakagawa, Y. Preferential formation of the hydroperoxide of linoleic acid in choline glycerophospholipids in human erythrocytes membrane during peroxidation with an azo initiator. Free Radic. Biol. Med. 18, 1003\u20131012 (1995).","journal-title":"Free Radic. Biol. Med."},{"key":"68325_CR94","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1474-9726.2005.00159.x","volume":"4","author":"J Zheng","year":"2005","unstructured":"Zheng, J. et al. Calorie restriction delays lipid oxidative damage in Drosophila melanogaster. Aging Cell 4, 209\u2013216 (2005).","journal-title":"Aging Cell"},{"key":"68325_CR95","doi-asserted-by":"crossref","unstructured":"Agostini, F., Bubacco, L., Chakrabarti, S. & Bisaglia, M. \u03b1-Synuclein toxicity in Drosophila melanogaster is enhanced by the presence of iron: implications for Parkinson\u2019s disease. Antioxidants 12, 261 (2023).","DOI":"10.3390\/antiox12020261"},{"key":"68325_CR96","first-page":"1465","volume":"21","author":"B Grasl-Kraupp","year":"1995","unstructured":"Grasl-Kraupp, B. et al. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21, 1465\u20131468 (1995).","journal-title":"Hepatology"},{"key":"68325_CR97","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3892\/ijmm.2020.4770","volume":"47","author":"Z He","year":"2021","unstructured":"He, Z. et al. Role of ferroptosis induced by a high concentration of calcium oxalate in the formation and development of urolithiasis. Int. J. Mol. Med. 47, 289\u2013301 (2021).","journal-title":"Int. J. Mol. Med."},{"key":"68325_CR98","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5080843","volume":"2019","author":"L-J Su","year":"2019","unstructured":"Su, L.-J. et al. Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid. Med. Cell. Longev. 2019, 5080843 (2019).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"68325_CR99","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41586-024-07516-8","volume":"630","author":"CN Byrns","year":"2024","unstructured":"Byrns, C. N. et al. Senescent glia link mitochondrial dysfunction and lipid accumulation. Nature 630, 475\u2013483 (2024).","journal-title":"Nature"},{"key":"68325_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.11.022","volume":"316","author":"IY Quiroga","year":"2021","unstructured":"Quiroga, I. Y., Pellon-Maison, M., Gonzalez, M. C., Coleman, R. A. & Gonzalez-Baro, M. R. Triacylglycerol synthesis directed by glycerol-3-phosphate acyltransferases -3 and -4 is required for lipid droplet formation and the modulation of the inflammatory response during macrophage to foam cell transition. Atherosclerosis 316, 1\u20137 (2021).","journal-title":"Atherosclerosis"},{"key":"68325_CR101","doi-asserted-by":"publisher","first-page":"27299","DOI":"10.1074\/jbc.M113.485219","volume":"288","author":"AA Wendel","year":"2013","unstructured":"Wendel, A. A., Cooper, D. E., Ilkayeva, O. R., Muoio, D. M. & Coleman, R. A. Glycerol-3-phosphate acyltransferase (GPAT)-1, but not GPAT4, incorporates newly synthesized fatty acids into triacylglycerol and diminishes fatty acid oxidation *. J. Biol. Chem. 288, 27299\u201327306 (2013).","journal-title":"J. Biol. Chem."},{"key":"68325_CR102","doi-asserted-by":"publisher","first-page":"25629","DOI":"10.1074\/jbc.M503181200","volume":"280","author":"LE Hammond","year":"2005","unstructured":"Hammond, L. E. et al. Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs. J. Biol. Chem. 280, 25629\u201325636 (2005).","journal-title":"J. Biol. Chem."},{"key":"68325_CR103","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1021\/jm900251a","volume":"52","author":"EA Wydysh","year":"2009","unstructured":"Wydysh, E. A., Medghalchi, S. M., Vadlamudi, A. & Townsend, C. A. Design and synthesis of small molecule glycerol 3-phosphate acyltransferase inhibitors. J. Med. Chem. 52, 3317\u20133327 (2009).","journal-title":"J. Med. Chem."},{"key":"68325_CR104","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/0748730411414264","volume":"26","author":"B Schmid","year":"2011","unstructured":"Schmid, B., Helfrich-F\u00f6rster, C. & Yoshii, T. A new ImageJ plug-in \u201cActogramJ\u201d for chronobiological analyses. J. Biol. Rhythms 26, 464\u2013467 (2011).","journal-title":"J. Biol. Rhythms"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68325-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68325-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68325-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:04:14Z","timestamp":1770995054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68325-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68325"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68325-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4199316\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"1 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1618"}}